Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rHuKGF for Oral Mucositis in Hematologic Malignancies
NCT00004132Phase 2Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Jan 2000
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of palifermin in oral mucositis (OM) (3 arms), sponsored by UCLA Jonsson Comprehensive Cancer Center. Primary endpoint: Duration of severe oral mucositis. Started Jan 2000; status: completed.
02
Drugs
palifermin
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT00004132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004132.